Evaluation of the Bexa Breast Examination (BBE) As an Effective Solution to Breast Cancer Early Detection.

The article discusses a clinical trial, NCT06643767, evaluating the Bexa Breast Examination (BBE) as a solution for early breast cancer detection. The study aims to compare the BBE to digital breast tomosynthesis in detecting breast masses and cancer in women over 30. The Bexa device uses pressure elastography and focused ultrasound to identify abnormal breast masses, providing immediate results and potentially reducing unnecessary referrals for additional imaging studies. The trial is not yet recruiting participants and is expected to be completed by May 31, 2025. [Extracted from the article]